Moderna
MRNA
NASDAQ
IPO2018
about MRNA
Moderna is a biotechnology company focused on developing vaccines and therapeutic agents using messenger RNA (mRNA) technology.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $27.01 | $27.37 | $26.55 | $10.44B | 6.71M |
| eps |
price to earnings |
price to sales |
operating margin |
profit margin |
yield |
| -$2.13 | n/a | 73.12 | -638.73% | -580.99% | 0% |